MedPath

A clinical study to evaluate the effect of Matrustanya in Opthalmia neonatarum.

Phase 2
Conditions
Health Condition 1: H109- Unspecified conjunctivitis
Registration Number
CTRI/2024/02/062498
Lead Sponsor
Tilak Ayurved Mahavidyalaya ,Pune
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Neonates suffering from Kukunaka

term baby

Neonate 0 to 28 days

Babies weight greater than 2500 gm

Parents willing for treatment

Exclusion Criteria

preterm babies

baby weight less than 2500 gm

lacrimal duct atresia

NICU babies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
o itching, lacrimation,photophobia, congestionTimepoint: 1,2,3,4,5,6,7,8th
Secondary Outcome Measures
NameTimeMethod
decrease irritability due to Itching, decrease lacrimation & congestion, taking feed wellTimepoint: 1,2,3,4,5,6,7,8th
© Copyright 2025. All Rights Reserved by MedPath